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sion, including acute and delayed immunologic reac-
tions, transfusion-associated graft-versus-host disease,
viral hepatitis, and retrovirus transmission.1-11 This con-
cept may be especially beneficial to children.10,11
Preoperative autologous donation (PAD) of blood is an
effective method of blood conservation in cardiac
surgery that has been applied to patients as young as 4
years of age.5-11 In cooperative children weighing at
least 30 kg, PAD can be performed as easily as in adult
patients. However, PAD in younger or smaller children
entails several problems, including noncompliance dur-
ing blood collection, relatively small blood volume, and
remarkable hemodilution during cardiopulmonary
bypass (CPB).10-15 The present study clarifies the clini-
cal significance of PAD for a simple cardiac anomaly in
B lood conservation has become an essential conceptin cardiac operations because it can prevent serious
complications caused by homologous blood transfu-
Objective: Preoperative autologous donation of blood has been expanded to
cardiac operations in children. However, because of problems such as lack of
cooperation and hemodilution during cardiopulmonary bypass, its efficacy in
small children is unclear. This study clarifies the clinical significance of pre-
operative autologous donation of blood in small children.
Methods: Thirty-seven patients weighing under 20 kg (age range, 3-9 years;
weight range, 13-20 kg) underwent preoperative autologous donation and
cardiac operations to treat a simple anomaly. Twenty-five age- and weight-
matched patients who were not cooperative or refused preoperative autolo-
gous donation served as control subjects. Autologous blood was collected by
the simple or leapfrog method and stored as blood components. Each col-
lecting volume was 5 to 10 mL/kg.
Results: The donation was performed 6 ± 2 times during 50 ± 16 days, and
the whole storage volume was 48 ± 17 mL/kg. There was no serious com-
plication. The minimum hematocrit level negatively correlated with the
priming volume of cardiopulmonary bypass (preoperative donation patients:
P < .01, r2 = 0.4; control subjects: P = .5, r2 = 0.03). Blood loss did not sig-
nificantly differ between preoperative donation patients and control subjects,
and the transfused blood volumes were 43 ± 13 mL/kg and 29 ± 22 mL/kg,
respectively. All of the autologous blood products but fresh frozen plasma
were reinfused. Use of homologous blood was significantly less in preoper-
ative donation patients than in control subjects (0% vs 80%, P < .01). In pre-
operative donation patients postoperative recovery in hemoglobin level was
significantly better, which is concurrent with a higher reticulocyte level.
Conclusion: Preoperative autologous donation can be performed safely with
clinical efficacy, even in children under 20 kg. This can be improved further
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small children by analyzing the surgical results of
patients weighing less than 20 kg.
Methods
From December 1992 to March 1999, 134 children aged
0 to 16 years underwent cardiac operations for simple
anomalies in our institution. Almost all of them were
regarded as PAD candidates, and the first donation was
planned approximately 1 month before surgery. Among
these candidates, 37 patients weighing under 20 kg accept-
ed PAD. The range of weight was 13 to 20 kg (19 ± 2 kg),
and that of age was 3 to 9 years (6 ± 1 years). Their anom-
alies were atrial septal defect (n = 22), ventricular septal
defect (n = 12), double-chambered right ventricle (n = 1),
left ventricular–right atrial communication (n = 1), and aor-
tic valvular stenosis (n = 1). Within the preceding weight
and age ranges, there were 25 patients who were excluded
from the PAD protocol during the same period. Their
weights and ages ranged from 13 to 19 kg (18 ± 2 kg) and 4
to 8 years (6 ± 2 years), respectively. The anomalies were
atrial septal defect (n = 15) and ventricular septal defect (n
= 10). The reasons for exclusion were poor cooperation and
refusal for fear, locomotive problems, and religious forbid-
dance. These patients served as control subjects.
Informed consent was obtained from patients and family
members during the initial visit. The PAD procedure was
clearly explained to ensure complete understanding and com-
pliance by the patient during blood donation. About 1 month
before the operation, the patient and family visited the blood
transfusion unit. Throughout blood donation, the staff and
family, usually the mother, encouraged or relaxed the patient
by various methods. Only local anesthetic agent was applied
to the puncture site, usually the upper limb. After confirming
that the hemoglobin level was greater than 11 g/dL, the
patient’s blood was withdrawn and processed into packed red
cells, fresh frozen plasma, and whole blood. The preserving
solution was mannitol-adenine-phosphate solution, which
allows up to 6 weeks’ storage. Five to 10 mL/kg autologous
blood was obtained at every donation, which was performed
by simple withdrawal and storage or the leapfrog method.16
We usually selected the simple method for the patient with a
PAD period of less than 4 weeks and the leapfrog method for
the patient with a longer PAD period. In the latter, withdraw-
al of blood was followed by reinfusion and withdrawal of
additional blood at 1- to 2-week intervals, yielding fresh
whole blood, packed red cells, and fresh frozen plasma. We
scheduled the final storage volume of the autologous blood to
be approximately 40 mL/kg.
For conservation of the patient’s blood, blood was salvaged
by conventional ultrafiltration and cell processing during the
operation, and residual blood in the CPB circuit was returned
to the patient within the operative day. The other procedures
for blood conservation, such as acute normovolemic hemo-
dilution, pharmacologic measures, and postoperative auto-
transfusion of shed mediastinal blood were not performed.
Criteria for blood transfusion included anemia with a hema-
tocrit level of less than 15% during CPB and a hemoglobin
level of less than 8 g/dL after CPB or circulatory disturbance
with mixed venous oxygen saturation of less than 60%
despite adequate cardiac output, as estimated by clinical
impression or echocardiography. In addition, whole autolo-
gous blood, except fresh frozen plasma, was reinfused within
the first postoperative day.
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Table I. Preoperative patient profiles
Variables PAD patients (n = 37) Control subjects (n = 25) P value
Age (y) 6 ± 1 6 ± 2 .9
Weight (kg) 19 ± 2 18 ± 2 .5
Sex (M/F) 23/14 14/11 .6
Diagnosis
ASD (%) 22 (60) 15 (60)
VSD (%) 12 (32) 10 (40) .7
Others 3 (8) 0 (0)
Pre-PAD levels*
Hemoglobin (g/dL) 12.7 ± 0.8 13.0 ± 0.9 .12
Reticulocytes (0/00) 10 ± 4 10 ± 6 .2
Platelets (103/µL) 278 ± 64 280 ± 101 .96
Total protein (g/dL) 6.9 ± 0.4 6.8 ± 0.5 .6
Preoperative levels
Hemoglobin (g/dL) 11.6 ± 0.9 13.0 ± 1.1 <.01
Reticulocytes (0/00) 25 ± 11 13 ± 5 <.01
Platelets (103/µL) 302 ± 70 303 ± 66 .98
Total protein (g/dL) 6.7 ± 0.4 7.3 ± 0.4 <.01
Data are given as mean ± SD where indicated. ASD, Atrial septal defect; VSD, ventricular septal defect; others, double-chambered right ventricle (n = 1), left ven-
tricular–right atrial communication (n = 1), and aortic valvular stenosis.
*One month before the operation in the control group.
Surgery consisted of primary intracardiac repair of a sim-
ple anomaly. The CPB circuit was primed with asanguineous
solution. After systemic heparinization, mild-to-moderate
hypothermic CPB was used with a hollow-fiber membrane
oxygenator. Myocardial protection was achieved by means of
cold blood cardioplegia, and topical myocardial cooling was
achieved by means of cold saline solution. Before discontin-
uation of CPB, all patients were warmed to a rectal tempera-
ture of 36°C or more. The heparin effect was neutralized by
protamine sulfate until the activated coagulation time had
normalized.
Patient profile and PAD-related and operative factors were
studied. Complications related to autologous blood donation,
preservation, and reinfusion were surveyed throughout the
course. Exposure to homologous blood, excess autologous
blood, perioperative changes, and hemoglobin, reticulocyte,
platelet, and serum protein levels were examined.
Data are expressed as mean ± SD. Continuous variables,
such as fluid and blood volume, are generally expressed as
relative values to body weight. All statistical analyses were
conducted by JMP Statistical Discovery Software (SAS
Institute, Inc, Cary, NC). Differences in the mean and rate
were determined by the Student t test and the χ2 test. Changes
in the consecutive data were compared between the groups by
analysis of variance.
Results
Patient profiles, including age, weight, sex, and
diagnosis, did not differ significantly between PAD
patients and control subjects. Hemoglobin, reticulo-
cyte, platelet, and total protein levels were also similar
between the groups at the beginning. However, hemo-
globin and total protein levels immediately before the
operation were significantly lower in the PAD group
than in the control group. On the contrary, the reticu-
locyte level was significantly higher in the PAD group
(Table I).
PAD was initiated 50 ± 16 days (range, 20-72 days)
before the operation and was performed 6 ± 2 times.
The total volume of stored autologous blood was 48 ±
17 mL/kg per patient. According to component, autol-
ogous whole blood was 35 ± 15 mL/kg, packed red
cells were 22 ± 6 mL/kg, and fresh frozen plasma was
25 ± 26 mL/kg. During PAD, hemoglobin and total
protein levels decreased by 1.1 ± 1.1 g/dL and 0.4 ± 0.4
g/dL after PAD, respectively.
Two patients experienced a vasovagal reflex consist-
ing of faintness, nausea, and paleness, which was
caused by transient hypotension and bradycardia dur-
ing blood donation. They quickly recovered without
any further complications. Rethoracotomy was not
required in any of the patients, and no other complica-
tions, such as infection, thrombosis, or embolism, were
observed in the patients.
Surgical factors, including procedure, operation time,
perfusion time, priming volume, and the minimum
hematocrit level during CPB, did not differ significant-
ly between the groups (Table II). There was a negative
correlation between body weight and relative priming
volume (PAD group: P < .01, r2 = 0.2; control group:
P = .2, r2 = 0.08), as well as between the minimum
hematocrit level and relative priming volume (PAD
group: P < .01, r2 = 0.4; control group: P = .5, r2 = 0.03).
Blood loss did not significantly differ between the 2
groups. During the operation, blood loss was 7 ± 1
mL/kg in PAD patients and 6 ± 1 mL/kg in control sub-
jects (P = .3). Chest tube drainage during 24 hours after
the operation was 11 ± 4 mL/kg in PAD patients and 10
± 3 mL/kg in control subjects (P = .2).
Homologous blood was not transfused to any of the
PAD patients (0/37 [0%]), and 43 ± 13 mL/kg autolo-
gous blood was used overall. All of the donated whole
blood or packed red cells were transfused; however,
some of the fresh frozen plasma was not reinfused
(14/37 [38%] patients), amounting to 11 ± 6 mL/kg per
patient. In contrast, 20 (80%) of 25 control patients
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Table II. Surgical factors
Variables PAD patients (n = 37) Control subjects (n = 25) P value
Procedure
ASD closure (direct/patch) 22 (20/2) 15 (15/0)
VSD closure (direct/patch) 12 (10/2) 10 (10/0) .7
Others 3 0
Operation time (min) 191 ± 32 200 ± 27 .2
Perfusion time (min) 49 ± 26 46 ± 17 .6
Priming volume of CPB
Absolute (mL) 1164 ± 160 1214 ± 183 .3
Relative (mL/kg) 64 ± 9 66 ± 9 .2
Minimum hematocrit (%) 18 ± 2 18 ± 5 .14
Data are given as mean ± SD where indicated. ASD, Atrial septal defect; VSD, ventricular septal defect; direct, direct closure; patch, patch closure; others, intracardiac
repair for double-chambered right ventricle (n = 1), left ventricular–right atrial communication (n = 1), and open commissurotomy for congenital aortic stenosis.
were exposed to homologous blood (P < .01, PAD
patients vs control subjects). The mean transfused vol-
ume was 29 ± 22 mL/kg (P < .01, PAD patients vs con-
trol subjects).
The perioperative changes in hemoglobin level were
examined between the 2 groups. Just before the opera-
tion, the hemoglobin level was significantly lower in
the PAD group than in the control group. As mentioned
above, the hemoglobin level decreased by 1.1 ± 1.1
g/dL in the PAD group, and the corresponding figure
was 0.1 ± 0.4 g/dL in the control group (P < .01).
Bleeding ceased quickly, and chest drains were
removed within the first postoperative day. Blood trans-
fusion was discontinued until the second postoperative
day in all of the patients. The hemoglobin level reached
a nadir on the first postoperative day and then increased
in the PAD group. That of the control group decreased
monotonously until the seventh postoperative day (Fig
1, A). Change of hemoglobin level from the second to
the seventh postoperative day was significantly larger
in the PAD group than in the control group (0.6 ± 1.3
g/dL vs –1.1 ± 1.0 g/dL, respectively; P < .01). From
the preoperative day to the second postoperative day,
the reticulocyte level of the PAD group was around 25
0/00, which was significantly higher than that of the
control group (Fig 1, B). However, a significant differ-
ence was not found thereafter between the groups.
Changes in platelet counts did not differ significant-
ly between the PAD and control groups throughout the
course of treatment (Fig 2, A). Mean values decreased
below 200 × 103/µL on the first and second postopera-
tive days and recovered to preoperative levels by the
seventh postoperative day. The total protein level was
significantly lower in the PAD group than in the control
group immediately before the operation (Fig 2, B). It
reached the lowest level on the first postoperative day
and changed very little thereafter in either group
throughout the course of treatment.
Comment
Children tend to be susceptible to infection and
immune disorders because their immune system has
not yet completely matured.10 Consequently, complica-
tions caused by homologous blood transfusion can be
more severe in children than in adults. Carriers of
human T-lymphotropic virus type 1 (HTLV-1) consti-
tute approximately 15% of the population in the south-
ern Japanese island of Kyushu. This rate is remarkably
higher than corresponding values in nonendemic areas
(0.02%-0.04%).1-3 Screening for antibodies to HTLV-1
is routinely performed here. However, seroconversion
to HTLV-1 may occur even after screening donor
blood.1,2 Manifestation of HTLV-1–associated myelo-
pathy after cardiac surgery has also been reported in
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Fig 1. Perioperative changes in hemoglobin (A) and reticulocyte (B) levels. Closed circles and open circles repre-
sent the PAD and control groups, respectively. OP, Operation; POD, postoperative day. Data are given as mean ±
SD. *P < .05, PAD group versus control group.
A B
such patients.4 Similar findings have also been report-
ed in human HIV-1, hepatitis B virus, and hepatitis C
virus.1-3,5,6 In addition, because life expectancy is long
in children, the lifetime risk of overt infection, liver cir-
rhosis, or neoplasm caused by viral transmission will
be comparatively higher. Therefore, exposure to
homologous blood should be avoided as much as pos-
sible in children.10
To avoid homologous blood transfusion in cardiac
operations performed in children—in other words, to
conserve the patients’ own blood—several methods
have been studied clinically. They include PAD by liq-
uid or frozen storage, acute normovolemic hemodilu-
tion, reduced priming volume of CPB, blood salvage
by filtration or cell processing, modified ultrafiltration,
autotransfusion of shed mediastinal blood, and phar-
macologic means.9,10,12-18
There are not many articles about PAD for children in
the current era. Masuda and colleagues11 conducted
PAD for 80 patients with a mean weight of 29 kg
(range, 12-69 kg). They donated 735 ± 388 mL of
autologous blood and avoided allogenic transfusion in
94% of patients. Although they conclude that PAD is a
safe and effective method, there are some authors who
claim it is a bothersome and outdated technique.8 Most
of the blood conservation procedures attempt to reduce
hemodilution caused by CPB. The present results
exhibit a negative correlation between relative priming
volume and hematocrit level, indicating that decreasing
hemodilution is a reasonable and effective approach in
children.9,10,12,13 On the other hand, autotransfusion of
shed mediastinal blood remains controversial because
of the risk of bacterial contamination or activation of
the systemic inflammatory response.9,10 Pharmacologic
means are applied to facilitate erythropoiesis, improve
coagulation, or inhibit fibrinolysis, resulting in favor-
able outcomes.9,10,15,17
Almost all measures except PAD are usually con-
ducted during or immediately after surgery, a busy and
vulnerable period. On the other hand, PAD is per-
formed before surgery and thus does not affect surgical
time. PAD is also the only method that increases the
absolute volume of the patient’s own blood. In the 
present study there were no serious complications
related to PAD, and none of these patients required
homologous blood. In addition, postoperative recovery
of the hemoglobin level was significantly better in the
PAD group and was accompanied by a higher reticulo-
cyte level. This suggests flourishing erythropoiesis
ascribed to PAD. These results indicate the clinical effi-
cacy of PAD in prevention of homologous blood trans-
fusion in children.
Despite these positive findings, PAD has not seen
widespread acceptance in cardiac operations in chil-
dren.9-11 Recent improvements in CPB, resulting in a
remarkable decrease in the priming volume, likely
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Fig 2. Perioperative changes in platelet (A) and total protein (B) levels. Closed circles represent PAD patients, and
open circles represent control subjects. OP, Operation; POD, postoperative day. Data are given as mean ± SD. 
*P < .05, PAD patients versus control subjects.
A B
explain this lack of acceptance of PAD. Other factors
include family stress, the lengthy donation period, the
labor intensiveness of the procedure, and concerns
about worsening the primary cardiac lesion. However,
PAD can be coupled with other methods to reduce the
storage volume, which may be a direct and effective
means of resolving these problems. As an alternative,
blood collection during cardiac catheterization, phar-
macologic activation of erythropoiesis, improved
preservation solutions, and simplification of the proce-
dures may also be of benefit. In the present study the
absolute priming volume of our CPB system was ini-
tially 1000 to 1200 mL. This has since been reduced to
600 to 800 mL. As to the influence of this reduction of
priming volume, we found a significant decrease in
allogenic blood exposure in the control group (15/16
patients with priming volumes of > 800 mL and 5/9
patients with priming volumes from 600-800 mL; P =
.04). In the PAD group we could not find a significant
difference in the minimum hematocrit level during
CPB (17% ± 2% in patients of priming volume of >
800 mL vs 18% ± 3% in patients of priming volume
from 600-800 mL; P = .8). In addition, we changed the
preservation solution from a citrate-phosphate-dextrose
solution to a mannitol-adenine-phosphate solution,
which elongates the preservation period from 3 to 6
weeks. Through these alterations, none of our patients
now requires the leapfrog method for blood donation,
thus improving the efficacy of PAD.11 Given the unique
effects offered by PAD, this method continues to be an
important option of blood conservation in cardiac oper-
ations in children.
On the basis of the present study, we conclude that
PAD can be performed safely and can be clinically
effective, even in children under 20 kg. This technique
can be further improved through coupling with differ-
ent procedures for blood conservation.
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